Navigation Links
Spending on Diabetes Drugs Soars in US

One more indicator of the growing epidemic of diabetes in the US is out. Spending on diabetes drugs is spiraling by leaps and bounds .

According to a drug trend report released by the Medico Health Solutions, diabetes treatments trailed only cholesterol medications in total prescription drug spending growth in 2006.

An aging population and the alarming rise in obesity a leading cause of diabetes are expected to push spending growth rates on diabetes drugs up 16 percent to 20 percent annually.

The analysis projects that, by 2009, spending on medicines to treat diabetes could soar by 60 percent to 68 percent from 2006 levels. Spending on diabetes treatments increased 14.5 percent from 2005 to 2006 and the use of diabetes drugs increased 5.1 percent. The U.S. sales of diabetes drugs reached $9.88 billion in 2005.

Use is expected to increase by 8 percent to 10 percent each year, with patients more frequently using new drug combinations to reach target blood sugar levels, the Medco analysis of likely future prescription drug spending and utilization found.

There are going to be a lot more drugs coming out and more and more people with type 2 diabetes will catapult diabetes to the number one class in driving year over year spending growth, Dr. Lon Castle, director of medical policy for Medco, said in an interview.

A wave of new diabetes treatments, such as Merck & Co.s, Januvia, and Byetta from Eli Lilly and Co. and Amylin Pharmaceuticals Inc.; and others expected to hit the market from the likes of Novartis AG and Novo Nordisk A/S will help push up treatment costs, the report said.

Some newer drugs that act on new targets are increasingly being prescribed as first-line therapy and are frequently being used in combination with other drugs, driving up costs this year and going forward, the report said.

Use of lower cost generic drugs could mitigate pricing pressures, said Medco, a pharmacy benefits manager that negotiates prescription drug costs for companies and other large clients.

But while new medicines and combination therapies can be expensive, the cost of treating complications from untreated diabetes would create a much larger burden on government and private health plans and patient pocketbooks.

Diabetes and, in particular, type 2 diabetes, is becoming much more prevalent among people of all ages, Medco Chief Medical Officer Robert Epstein said in a statement.

While prevention of type 2 diabetes needs to be a national priority, drug treatments can help prevent the onset of complications from diabetes that lead to hospitalizations, more complex treatment and dramatically higher costs, Epstein said.


Related medicine news :

1. More Spending Does Not Ensure Better Healthcare
2. Western Australian Government Spending Extra For Mental Health Services
3. Lowest Spending growth in US Medicaid
4. Variation in U.S. Healthcare Spending
5. States Spending may Help Keep Childless Seniors Independent
6. Coverage for Childrens Mental Illness Reduces Out-of-Pocket Spending
7. G8 Members To Announce Plans To Increase HIV/AIDS Spending at Summit
8. Is Diabetes the Leading Cause of Kidney Failure in India
9. Diabetes and Depression often go hand-in-hand
10. Thirty minutes of work up per day reduces the risk of Diabetes
11. Diabetes on the rise
Post Your Comments:

(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: